Long-Term Safety Study of KW-6500 in Patients With Parkinson's Disease
-
- STATUS
- Not Recruiting
-
- participants needed
- 58
-
- sponsor
- Kyowa Kirin Co., Ltd.
Updated on 22 July 2024
Summary
The purpose of this study is to evaluate the safety and efficacy of KW-6500 when administered as long-term subcutaneous self-injections in Parkinson's disease patients with motor response complications on levodopa therapy.
Details
| Condition | Parkinson's Disease |
|---|---|
| Age | 20years or above |
| Treatment | KW-6500 |
| Clinical Study Identifier | NCT00955318 |
| Sponsor | Kyowa Kirin Co., Ltd. |
| Last Modified on | 22 July 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.